Annual report pursuant to Section 13 and 15(d)

Segment Information - Financial Information Relating to Reportable Segments (Details)

v3.22.2.2
Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Revenues, net   $ 1,105,599 $ 931,032 $ 738,691
Operating income   296,590 237,296 157,419
Costs recognized on sale of acquired inventory   (1,596) (1,565)  
Amortization of acquisition related intangible assets   (73,054) (64,239) (60,865)
Impact of partially owned consolidated subsidiaries(1)   (2,393) (1,505)  
Gain on escrow settlement       7,169
Acquisition related expenses   19,070 (7,114) (416)
Eminence impairment   (18,715)    
Stock based compensation, inclusive of employer taxes   (46,401) (51,846) (34,262)
Restructuring costs $ (242) (1,640) (142) (87)
Corporate general, selling, and administrative expenses   (372,766) (324,951) (260,583)
Total long-lived assets 223,242 223,242 207,907  
Total intangible assets, net 531,522 531,522 615,968 516,545
United States and Canada [Member]        
Total long-lived assets 203,732 203,732 190,501  
Total intangible assets, net 523,536 523,536 594,512  
Europe [Member]        
Total long-lived assets 16,223 16,223 13,949  
Total intangible assets, net 6,281 6,281 9,369  
Asia [Member]        
Total long-lived assets 3,287 3,287 3,457  
Total intangible assets, net $ 1,705 1,705 12,087  
Consumables [Member]        
Revenues, net   890,874 751,985 602,642
Diagnostics and Genomics [Member]        
Restructuring costs   (1,400)    
Operating Segments [Member]        
Operating income   426,600 368,650 249,894
Operating Segments [Member] | Consumables [Member]        
Revenues, net   890,874 751,985 602,642
Operating Segments [Member] | Protein Sciences [Member]        
Revenues, net   832,311 704,564 555,352
Operating income   377,623 330,225 234,929
Operating Segments [Member] | Protein Sciences [Member] | Consumables [Member]        
Revenues, net   646,952 557,037 431,052
Operating Segments [Member] | Diagnostics and Genomics [Member]        
Revenues, net   274,843 227,744 184,549
Operating income   48,977 38,425 14,965
Operating Segments [Member] | Diagnostics and Genomics [Member] | Consumables [Member]        
Revenues, net   243,922 194,948 171,590
Intersegment Eliminations [Member]        
Revenues, net   (1,555) (1,276) (1,210)
Corporate, Non-Segment [Member]        
Corporate general, selling, and administrative expenses   $ (5,281) $ (4,943) $ (4,015)